|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance cost | |||||
| Share-based compensation | |||||
| Gain on sale of equity method investment | |||||
| Non-cash lease expense | |||||
| Gain on debt extinguishment | |||||
| Unrealized (gain) loss on investments | |||||
| Income from equity method investments, net | |||||
| Unrealized gain on interest rate swaps | |||||
| Gain on sale or distribution of investments | |||||
| Unrealized loss (gain) from investment in equity securities | |||||
| Deferred tax | |||||
| Change in fair value of contingent consideration liabilities | |||||
| Loss on consolidation of equity method investment | |||||
| Gain on contingent equity securities | |||||
| Gain from investment in warrants | |||||
| Impairment of beneficial interest | |||||
| Other | |||||
| Changes in operating assets and liabilities, net of business combinations | |||||
| Receivables, net | |||||
| Receivables, net - related parties | |||||
| Other receivables | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Fiduciary accounts payable | |||||
| Medical liabilities | |||||
| Income taxes payable/receivable | |||||
| Operating lease liabilities | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Payments for business and asset acquisition, net of cash acquired | |||||
| Proceeds from repayment of promissory notes, including those with related parties | |||||
| Purchases of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Purchases of investments – equity method | |||||
| Purchase of call option issued in conjunction with equity method investment | |||||
| Distribution from investment - equity method | |||||
| Contribution to investment - equity method | |||||
| Cash recorded from consolidation of VIE | |||||
| Issuance of loans receivable | |||||
| Purchases of property and equipment | |||||
| Purchases of investments –privately held | |||||
| Proceeds from sale of equity method investment | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Dividends paid | |||||
| Repayments on long-term debt | |||||
| Repayments on debt | |||||
| Borrowings on debt | |||||
| Borrowings on long-term debt | |||||
| Payment of finance lease obligations | |||||
| Proceeds from exercise of stock options and warrants | |||||
| Proceeds from sale of common stock | |||||
| Proceeds from ESPP purchases | |||||
| Taxes paid from net share settlement of restricted stock | |||||
| Repurchase of treasury shares | |||||
| Purchase of non-controlling interest | |||||
| Proceeds from sale of noncontrolling interest | |||||
| Deferred financing cost | |||||
| Payment of financing obligation | |||||
| Payment of contingent consideration liabilities | |||||
| Other | |||||
| Net cash provided by financing activities | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of year | |||||
| Cash, cash equivalents, and restricted cash, end of year | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Supplemental disclosures of non-cash investing and financing activities | |||||
| Right-of-use assets obtained in exchange for operating lease liabilities | |||||
| Common stock issued in business combination | |||||
| Common stock issued for contingent consideration payment | |||||
| Acquisition of business through loan conversion | |||||
| Draw on letter of credit through Revolver Loan | |||||
| Tax impact from APC dividends to APC Shareholders | |||||
| Distribution of real estate investments | |||||
| Dividend declared included in dividend payable | |||||
| Issuance of financing obligation for business combinations | |||||
| Cashless exercise of warrants | |||||
| Fixed asset obtained in exchange for finance lease liabilities | |||||
| Mortgage loan | |||||
| Cancellation of Restricted Stock Awards | |||||
| Effective settlement of note payable upon consolidation | |||||
| Transfer of investment in privately held to equity method | |||||
| Repurchase of treasury shares outstanding payable | |||||
| Dividend paid in form of stock | |||||
| Reconciliation of cash, cash equivalents, and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...